Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 37952

1.

Synergistic antidepressant-like effect of ferulic acid in combination with piperine: involvement of monoaminergic system.

Li G, Ruan L, Chen R, Wang R, Xie X, Zhang M, Chen L, Yan Q, Reed M, Chen J, Xu Y, Pan J, Huang W.

Metab Brain Dis. 2015 Jul 30. [Epub ahead of print]

PMID:
26220010
2.

Identification and treatment of depression of older adults in primary care: findings from the São Paulo Ageing and Health Study.

Scazufca M, Menezes P, Tabb K, Kester R, Rössler W, Huang H.

Fam Pract. 2015 Jul 28. pii: cmv062. [Epub ahead of print]

PMID:
26219991
3.

Basimglurant for treatment of major depressive disorder: a novel negative allosteric modulator of metabotropic glutamate receptor 5.

Fuxe K, Borroto-Escuela DO.

Expert Opin Investig Drugs. 2015 Jul 29:1-14. [Epub ahead of print]

PMID:
26219727
4.

EFFECTS OF RELIGIOUS VERSUS STANDARD COGNITIVE-BEHAVIORAL THERAPY ON OPTIMISM IN PERSONS WITH MAJOR DEPRESSION AND CHRONIC MEDICAL ILLNESS.

Koenig HG, Pearce MJ, Nelson B, Daher N.

Depress Anxiety. 2015 Jul 28. doi: 10.1002/da.22398. [Epub ahead of print]

PMID:
26219426
5.

Preschoolers' Psychopathology and Temperament Predict Mothers' Later Mood Disorders.

Allmann AE, Kopala-Sibley DC, Klein DN.

J Abnorm Child Psychol. 2015 Jul 30. [Epub ahead of print]

PMID:
26219263
6.

Immune and neurotrophin stimulation by electroconvulsive therapy: is some inflammation needed after all?

van Buel EM, Patas K, Peters M, Bosker FJ, Eisel UL, Klein HC.

Transl Psychiatry. 2015 Jul 28;5:e609. doi: 10.1038/tp.2015.100. Review.

PMID:
26218851
7.

Glia in the cytokine-mediated onset of depression: fine tuning the immune response.

Jo WK, Zhang Y, Emrich HM, Dietrich DE.

Front Cell Neurosci. 2015 Jul 10;9:268. doi: 10.3389/fncel.2015.00268. eCollection 2015. Review.

8.

Understanding the role of P2X7 in affective disorders-are glial cells the major players?

Stokes L, Spencer SJ, Jenkins TA.

Front Cell Neurosci. 2015 Jul 8;9:258. doi: 10.3389/fncel.2015.00258. eCollection 2015. Review.

9.

Heart rate variability in major depressive disorder and after antidepressant treatment with agomelatine and paroxetine: Findings from the Taiwan Study of Depression and Anxiety (TAISDA).

Yeh TC, Kao LC, Tzeng NS, Kuo TB, Huang SY, Chang CC, Chang HA.

Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jul 24. pii: S0278-5846(15)30015-4. doi: 10.1016/j.pnpbp.2015.07.007. [Epub ahead of print]

PMID:
26216863
10.

High-throughput sequencing of the synaptome in major depressive disorder.

Pirooznia M, Wang T, Avramopoulos D, Potash JB, Zandi PP, Goes FS.

Mol Psychiatry. 2015 Jul 28. doi: 10.1038/mp.2015.98. [Epub ahead of print]

PMID:
26216301
11.

Molecular and Genetic Characterization of Depression: Overlap with other Psychiatric Disorders and Aging.

Ding Y, Chang LC, Wang X, Guilloux JP, Parrish J, Oh H, French BJ, Lewis DA, Tseng GC, Sibille E.

Mol Neuropsychiatry. 2015 May;1(1):1-12.

PMID:
26213687
12.

Prevalence of mental health disorders in inflammatory bowel disease: an Australian outpatient cohort.

Tribbick D, Salzberg M, Ftanou M, Connell WR, Macrae F, Kamm MA, Bates GW, Cunningham G, Austin DW, Knowles SR.

Clin Exp Gastroenterol. 2015 Jul 17;8:197-204. doi: 10.2147/CEG.S77567. eCollection 2015.

13.

Two Cellular Hypotheses Explaining Ketamine's Antidepressant Actions: Direct Inhibition and Disinhibition.

Miller OH, Moran JT, Hall BJ.

Neuropharmacology. 2015 Jul 23. pii: S0028-3908(15)30035-6. doi: 10.1016/j.neuropharm.2015.07.028. [Epub ahead of print] Review.

PMID:
26211972
14.

5Hz Repetitive transcranial magnetic stimulation to left prefrontal cortex for major depression.

Philip NS, Carpenter SL, Ridout SJ, Sanchez G, Albright SE, Tyrka AR, Price LH, Carpenter LL.

J Affect Disord. 2015 Jul 17;186:13-17. doi: 10.1016/j.jad.2014.12.024. [Epub ahead of print]

PMID:
26210705
15.

Peripheral vascular endothelial growth factor as a novel depression biomarker: A meta-analysis.

Carvalho AF, Köhler CA, McIntyre RS, Knöchel C, Brunoni AR, Thase ME, Quevedo J, Fernandes BS, Berk M.

Psychoneuroendocrinology. 2015 Jul 8;62:18-26. doi: 10.1016/j.psyneuen.2015.07.002. [Epub ahead of print] Review.

PMID:
26210676
16.

Child Gain Approach and Loss Avoidance Behavior: Relationships With Depression Risk, Negative Mood, and Anhedonia.

Luking KR, Pagliaccio D, Luby JL, Barch DM.

J Am Acad Child Adolesc Psychiatry. 2015 Aug;54(8):643-51. doi: 10.1016/j.jaac.2015.05.010. Epub 2015 Jun 5.

PMID:
26210333
17.

The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Rosenblat JD, Kakar R, McIntyre RS.

Int J Neuropsychopharmacol. 2015 Jul 25. pii: pyv082. doi: 10.1093/ijnp/pyv082. [Epub ahead of print]

18.

The gray matter alterations in major depressive disorder and panic disorder: Putative differences in the pathogenesis.

Lai CH, Wu YT.

J Affect Disord. 2015 Jul 14;186:1-6. doi: 10.1016/j.jad.2015.07.022. [Epub ahead of print]

PMID:
26208214
19.

CDH13 and HCRTR2 May Be Associated with Hypersomnia Symptom of Bipolar Depression: A Genome-Wide Functional Enrichment Pathway Analysis.

Cho CH, Lee HJ, Woo HG, Choi JH, Greenwood TA, Kelsoe JR.

Psychiatry Investig. 2015 Jul;12(3):402-7. doi: 10.4306/pi.2015.12.3.402. Epub 2015 Jul 6.

20.

Microarray Analysis of the Major Depressive Disorder mRNA Profile Data.

Gao L, Gao Y, Xu E, Xie J.

Psychiatry Investig. 2015 Jul;12(3):388-96. doi: 10.4306/pi.2015.12.3.388. Epub 2015 Jul 6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk